1535 related articles for article (PubMed ID: 17486461)
1. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
[TBL] [Abstract][Full Text] [Related]
2. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
Joseph O; Biodun O; Michael E
J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
[TBL] [Abstract][Full Text] [Related]
5. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
[TBL] [Abstract][Full Text] [Related]
6. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
7. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
9. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
[TBL] [Abstract][Full Text] [Related]
10. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
Cotter AM; Garcia AG; Duthely ML; Luke B; O'Sullivan MJ
J Infect Dis; 2006 May; 193(9):1195-201. PubMed ID: 16586354
[TBL] [Abstract][Full Text] [Related]
11. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
12. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
[TBL] [Abstract][Full Text] [Related]
13. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
14. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
[TBL] [Abstract][Full Text] [Related]
16. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
17. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
Martin F; Taylor GP
J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
[TBL] [Abstract][Full Text] [Related]
18. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
19. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; Martínez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
20. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
